Nanotechnology in stem cell research and therapy
Source abstract
Abstract
The ability for stem cell therapy in degenerative diseases and the replacement of organs has shown promising results in preclinical research. However, its therapeutic use remains limited even after several years of study. There is currently no single product or protocol based on stem cell therapy. Nanotechnology has shown tremendous potential and gained momentum in stem cell research and therapy due to its several characteristics like tunnel effects, quantum size effects, scale, and surface effects. Its importance is now being recognized specifically in the conformity, replication, and differentiation of stem cells. It has always been an area of interesting study for tissue engineering and regenerative medicine. Although there are many possibilities that nanotechnology may improve cell therapy and stem cell technology, still there are many cytotoxic threats, affecting the viability, stem cell differentiation, etc., that are associated. In this paper, some of the advancements and viewpoints on the use of nanotechnology in stem cell research and stem cell therapy have been discussed along with the application of nanoparticle in isolation tracking, regulation, and enhancing retention of stem cells. The article also discusses the problems, implementations, and challenges in the field that would strengthen the viewpoint and open up new directions/paths for future studies in the field.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Molecular Communication and Nanonetworks
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Farzamfar S et al (2019) Will nanotechnology bring new hope for stem cell therapy? Cells Tissues Organs 206(4–5):229–241
2. Weissman IL (2002) Stem cells — scientific, medical, and political issues. N Engl J Med 346(20):1576–1579. https://doi.org/10.1056/nejmsb02069310.1056/nejmsb020693 ↗
3. Solanki A, Kim JD, Lee KB (2008) Nanotechnology for regenerative medicine: nanomaterials for stem cell imaging. Nanomedicine 3(4):567–578. https://doi.org/10.2217/17435889.3.4.56710.2217/17435889.3.4.567 ↗
4. Gomes MJ, das Neves J, Sarmento B (2014) Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system. Int J Nanomedicine 9:1757–1769. https://doi.org/10.2147/IJN.S4588610.2147/IJN.S45886 ↗
5. Orkin SH, Morrison SJ (2002) Stem-cell competition. Nature 418(6893):25–27. https://doi.org/10.1038/418025a10.1038/418025a ↗
6. Jiang Y et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41–49. https://doi.org/10.1038/nature0087010.1038/nature00870 ↗
7. Khurana V, Kwatra D, Shah S, Mandal A, Mitra AK (2017) Emerging nanotechnology for stem cell therapy. In: Emerging nanotechnologies for diagnostics, drug delivery and medical devices. Elsevier Inc, pp 85–103. https://www.worldcat.org/title/emerging-nanotechnologies-for-diagnostics-drug-delivery-and-medical-devices/oclc/95987545310.1016/B978-0-323-42978-8.00005-X ↗
8. Spitalieri P, Talarico VR, Murdocca M, Novelli G, Sangiuolo F (2016) Human induced pluripotent stem cells for monogenic disease modelling and therapy. World J Stem Cells 8(4):118–13510.4252/wjsc.v8.i4.118 ↗
9. Metcalf D (2007) Concise review: Hematopoietic stem cells and tissue stem cells: current concepts and unanswered questions. Stem Cells 25(10):2390–2395. https://doi.org/10.1634/stemcells.2007-054410.1634/stemcells.2007-0544 ↗
10. M Calin, D Stan, and V Simion. Stem cell regenerative potential combined with nanotechnology and tissue engineering for myocardial regeneration.
11. Cui D (2007) Advances and prospects on biomolecules functionalized carbon nanotubes. J Nanosci Nanotechnol 7(4–5):1298–1314. https://doi.org/10.1166/jnn.2007.65410.1166/jnn.2007.654 ↗
12. Ferreira L, Karp JM, Nobre L, Langer R (2008) New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell 3(2):136–146. https://doi.org/10.1016/j.stem.2008.07.02010.1016/j.stem.2008.07.020 ↗
13. Moghimi SM, Hunter AC, Murray JC (2005) Nanomedicine: current status and future prospects. FASEB J 19(3):311–330. https://doi.org/10.1096/fj.04-2747rev10.1096/fj.04-2747rev ↗
14. Sun Y, Lu Y, Yin L, Liu Z (2020) The roles of nanoparticles in stem cell-based therapy for cardiovascular disease. Front Bioeng Biotechnol 8:947. https://doi.org/10.3389/FBIOE.2020.00947/BIBTEX10.3389/FBIOE.2020.00947/BIBTEX ↗
15. Mwai LM, Kyama MC, Ngugi CW, Walong E (2020) Bioconjugation of AuNPs with HPV 16/18 E6 antibody through physical adsorption technique. J Nanotechnol Nanomater 1(1):16–22. https://doi.org/10.33696/NANOTECHNOL.1.00410.33696/NANOTECHNOL.1.004 ↗
16. Gavas S, Quazi S, Karpiński TM (2021) Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res. Lett 16(1):1–21. https://doi.org/10.1186/S11671-021-03628-610.1186/S11671-021-03628-6 ↗
17. Kamkaew A, Chen F, Zhan Y, Majewski RL, Cai W (2016) Scintillating nanoparticles as energy mediators for enhanced photodynamic therapy. ACS Nano 10(4):3918–3935. https://doi.org/10.1021/ACSNANO.6B01401/ASSET/IMAGES/LARGE/NN-2016-01401D_0006.JPEG10.1021/ACSNANO.6B01401/ASSET/IMAGES/LARGE/NN-2016-01401D_0006.JPEG ↗
18. Werengowska-Ciećwierz K, Wis̈niewski KM, Terzyk AP, Furmaniak S (2015) The chemistry of bioconjugation in nanoparticles-based drug delivery system. Adv. Condens. Matter Phys 2015:1–27. https://doi.org/10.1155/2015/19817510.1155/2015/198175 ↗
19. Stephan MT, Moon JJ, Um SH, Bersthteyn A, Irvine DJ (2010) Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med 16(9):1035–1041. https://doi.org/10.1038/NM.219810.1038/NM.2198 ↗
20. Bhana S, Wang Y, Huang X (2015) Nanotechnology for enrichment and detection of circulating tumor cells. Nanomedicine 10(12):1973–1990. https://doi.org/10.2217/nnm.15.3210.2217/nnm.15.32 ↗
21. He J, Huang M, Wang D, Zhang Z, Li G (2014) Magnetic separation techniques in sample preparation for biological analysis: a review. J Pharm Biomed Anal 101:84–101. https://doi.org/10.1016/j.jpba.2014.04.01710.1016/j.jpba.2014.04.017 ↗
22. Chandra S, Nigam S, Bahadur D (2014) Combining unique properties of dendrimers and magnetic nanoparticles towards cancer theranostics. J Biomed Nanotechnol 10(1):32–49. https://doi.org/10.1166/jbn.2014.169810.1166/jbn.2014.1698 ↗
23. Wang R, Hu Y, Zhao N, Xu FJ (2016) Well-defined peapod-like magnetic nanoparticles and their controlled modification for effective imaging guided gene therapy. ACS Appl Mater Interfaces 8(18):11298–11308. https://doi.org/10.1021/acsami.6b0169710.1021/acsami.6b01697 ↗
24. Wang Z, Ruan J, Cui D (2009) Advances and prospect of nanotechnology in stem cells. Nanoscale Res Lett 4(7):593–605. https://doi.org/10.1007/s11671-009-9292-z10.1007/s11671-009-9292-z ↗
25. Jing Y et al (2007) Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis. Biotechnol Bioeng 96(6):1139–1154. https://doi.org/10.1002/bit.2120210.1002/bit.21202 ↗
26. Patel S, Lee K-B (2015) Probing stem cell behavior using nanoparticle-based approaches. Wiley Interdiscip Rev Nanomedicine Nanobiotechnol 7(6):759–778. https://doi.org/10.1002/wnan.134610.1002/wnan.1346 ↗
27. Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13(6):1266–1276. https://doi.org/10.1007/s00330-002-1721-710.1007/s00330-002-1721-7 ↗
28. Hsiao JK et al (2007) Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level. Magn Reson Med 58(4):717–724. https://doi.org/10.1002/mrm.2137710.1002/mrm.21377 ↗
29. Murahari M, Yergeri M (2013) Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer. Curr Pharm Des 19(25):4622–4640. https://doi.org/10.2174/138161281131925000910.2174/1381612811319250009 ↗
30. Jendelová P et al (2004) Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 76(2):232–243. https://doi.org/10.1002/jnr.2004110.1002/jnr.20041 ↗
31. Jin XH, Yang L, Duan XJ, Xie B, Li Z, Tan HB (2007) In vivo MR imaging tracking of supermagnetic iron-oxide nanoparticle-labeled bone marrow mesenchymal stem cells injected into intra-articular space of knee joints: experiment with rabbit. Natl Med J China 87(45):3213–3218
32. Shen J et al (2009) Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury. Acad Radiol 16(9):1142–1154. https://doi.org/10.1016/j.acra.2009.03.01610.1016/j.acra.2009.03.016 ↗
33. Liu Y et al (2011) Evaluation of cell tracking effects for transplanted mesenchymal stem cells with jetPEI/Gd-DTPA complexes in animal models of hemorrhagic spinal cord injury. Brain Res 1391:24–35. https://doi.org/10.1016/j.brainres.2011.03.03210.1016/j.brainres.2011.03.032 ↗
34. S Danner, H Benzin, T Vollbrandt, J Oder, A Richter, and C Kruse. Quantum dots do not alter the differentiation potential of pancreatic stem cells and are distributed randomly among daughter cells.Int J Cell Biolhttps://doi.org/10.1155/2013/91824210.1155/2013/918242 ↗
35. Lin S et al (2007) Quantum dot imaging for embryonic stem cells. BMC Biotechnol 7(1):67. https://doi.org/10.1186/1472-6750-7-6710.1186/1472-6750-7-67 ↗
36. Barnett JM, Penn JS, Jayagopal A (2013) Imaging of endothelial progenitor cell subpopulations in angiogenesis using quantum dot nanocrystals. Methods Mol Biol 2013:45–5610.1007/978-1-62703-468-5_4 ↗
37. B Shah, P Clark, M Stroscio, and J Mao (2006) Labeling and imaging of human mesenchymal stem cells with quantum dot bioconjugates during proliferation and osteogenic differentiation in long term. In: Annual International Conference of the IEEE Engineering in Medicine and Biology – Proceedings 2006 1470–1473 https://doi.org/10.1109/IEMBS.2006.260082.10.1109/IEMBS.2006.260082 ↗
38. Li J et al (2016) Multifunctional quantum dot nanoparticles for effective differentiation and long-term tracking of human mesenchymal stem cells in vitro and in vivo. Adv Healthc Mater 5(9):1049–1057. https://doi.org/10.1002/adhm.20150087910.1002/adhm.201500879 ↗
39. Ricles LM, Nam SY, Sokolov K, Emelianov SY, Suggs LJ (2011) Function of mesenchymal stem cells following loading of gold nanotracers. Int J Nanomedicine 6:407–416. https://doi.org/10.2147/ijn.s1635410.2147/ijn.s16354 ↗
40. Nam SY, Ricles LM, Suggs LJ, Emelianov SY (2012) In vivo ultrasound and photoacoustic monitoring of mesenchymal stem cells labeled with gold nanotracers. PLoS ONE 7(5):e37267. https://doi.org/10.1371/journal.pone.003726710.1371/journal.pone.0037267 ↗
41. Ricles LM, Nam SY, Treviño EA, Emelianov SY, Suggs LJ (2014) A dual gold nanoparticle system for mesenchymal stem cell tracking. J Mater Chem B 2(46):8220–8230. https://doi.org/10.1039/c4tb00975d10.1039/c4tb00975d ↗
42. Accomasso L et al (2012) Fluorescent silica nanoparticles improve optical imaging of stem cells allowing direct discrimination between live and early-stage apoptotic cells. Small 8(20):3192–3200. https://doi.org/10.1002/smll.20120088210.1002/smll.201200882 ↗
43. Gallina C et al (2015) Human mesenchymal stem cells labelled with dye-loaded amorphous silica nanoparticles: long-term biosafety, stemness preservation and traceability in the beating heart. J Nanobiotechnol 13(1):77. https://doi.org/10.1186/s12951-015-0141-110.1186/s12951-015-0141-1 ↗
44. JV Jokerst, C Khademi, and SS Gambhir (2013) Intracellular aggregation of multimodal silica nanoparticles for ultrasound-guided stem cell implantation. Sci. Transl. Med 5(177) https://doi.org/10.1126/scitranslmed.300522810.1126/scitranslmed.3005228 ↗
45. Novotna B et al (2016) The impact of silica encapsulated cobalt zinc ferrite nanoparticles on DNA, lipids and proteins of rat bone marrow mesenchymal stem cells. Nanotoxicol 10(6):662–670. https://doi.org/10.3109/17435390.2015.110714410.3109/17435390.2015.1107144 ↗
46. Lee JK, Chun SY, Im JY, Jin HK, Kwon TG, Bae JS (2012) Specific labeling of neurogenic, endothelial, and myogenic differentiated cells derived from human amniotic fluid stem cells with silica-coated magnetic nanoparticles. J Vet Med Sci 74(8):969–975. https://doi.org/10.1292/jvms.12-001610.1292/jvms.12-0016 ↗
47. Menon PK et al (2017) Intravenous administration of functionalized magnetic iron oxide nanoparticles does not induce CNS injury in the rat: influence of spinal cord trauma and cerebrolysin treatment. Int Rev Neurobiol 137:47–63. https://doi.org/10.1016/BS.IRN.2017.08.00510.1016/BS.IRN.2017.08.005 ↗
48. Sniadecki NJ, Desai RA, Ruiz SA, Chen CS (2006) Nanotechnology for cell-substrate interactions. Ann Biomed Eng 34(1):59–74. https://doi.org/10.1007/s10439-005-9006-310.1007/s10439-005-9006-3 ↗
49. Adams GB et al (2006) Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439(7076):599–603. https://doi.org/10.1038/nature0424710.1038/nature04247 ↗
50. Dolatshahi-Pirouz A, Nikkhah M, Kolind K, Dokmeci MR, Khademhosseini A (2011) Micro- and nanoengineering approaches to control stem cell-biomaterial interactions. J Funct Biomater 2(3):88–106. https://doi.org/10.3390/jfb203008810.3390/jfb2030088 ↗
51. Dolatshahi-Pirouz A et al (2015) A combinatorial cell-laden gel microarray for inducing osteogenic differentiation of human mesenchymal stem cells. Sci Rep 4(1):1–9. https://doi.org/10.1038/srep0389610.1038/srep03896 ↗
52. Zhou Y, Huang W, Liu J, Zhu X, Yan D (2010) Self-assembly of hyperbranched polymers and its biomedical applications. Adv Mater 22(41):4567–4590. https://doi.org/10.1002/adma.20100036910.1002/adma.201000369 ↗
53. Wang D, Tong G, Dong R, Zhou Y, Shen J, Zhu X (2014) Self-assembly of supramolecularly engineered polymers and their biomedical applications. Chem Commun 50(81):11994–12017. https://doi.org/10.1039/c4cc03155e10.1039/c4cc03155e ↗
54. Gelain F, Bottai D, Vescovi A, Zhang S (2006) Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures. PLoS ONE 1(1):e119. https://doi.org/10.1371/journal.pone.000011910.1371/journal.pone.0000119 ↗
55. Koutsopoulos S, Zhang S (2013) Long-term three-dimensional neural tissue cultures in functionalized self-assembling peptide hydrogels. Matrigel and collagen I Acta Biomater 9(2):5162–5169. https://doi.org/10.1016/j.actbio.2012.09.01010.1016/j.actbio.2012.09.010 ↗
56. Giri S, Nieber K, Acikgöz A, Pavlica S, Keller M, Bader A (2010) Telomerase activity and hepatic functions of rat embryonic liver progenitor cell in nanoscaffold-coated model bioreactor. Mol Cell Biochem 336(1–2):137–149. https://doi.org/10.1007/s11010-009-0266-310.1007/s11010-009-0266-3 ↗
57. Castells-Sala C, Sanchez B, Recha-Sancho L, Puig V, Bragos R, Semino CE (2012) Influence of electrical stimulation on 3D-cultures of adipose tissue derived progenitor cells (ATDPCs) behavior. Proc Annu Int Conf IEEE Eng Med Biol Soc 2012:5658–5661. https://doi.org/10.1109/EMBC.2012.634727810.1109/EMBC.2012.6347278 ↗
58. Tam K et al (2014) A nanoscaffold impregnated with human Wharton’s jelly stem cells or its secretions improves healing of wounds. J Cell Biochem 115(4):794–803. https://doi.org/10.1002/jcb.2472310.1002/jcb.24723 ↗
59. Elkhenany H et al (2015) Graphene supports in vitro proliferation and osteogenic differentiation of goat adult mesenchymal stem cells: potential for bone tissue engineering. J Appl Toxicol 35(4):367–374. https://doi.org/10.1002/jat.302410.1002/jat.3024 ↗
60. Mousavi SH, Abroun S, Soleimani M, Mowla SJ (2022) Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional nanoscaffold coated with fibronectin. Int. J. Hematol. Stem Cell Res 9(7):72
61. Aligholi H et al (2016) Preparing neural stem/progenitor cells in PuraMatrix hydrogel for transplantation after brain injury in rats: a comparative methodological study. Brain Res 1642:197–208. https://doi.org/10.1016/j.brainres.2016.03.04310.1016/j.brainres.2016.03.043 ↗
62. Mashhadikhan M, Soleimani M, Parivar K, Yaghmaei P (2020) ADSCs on PLLA/PCL hybrid nanoscaffold and gelatin modification: cytocompatibility and mechanical properties. Avicenna J Med Biotechnol 7(1):32–38
63. Gorjikhah F et al (2016) Improving ‘lab-on-a-chip’ techniques using biomedical nanotechnology: a review. Artif Cells Nanomedicine Biotechnol 44(7):1609–1614. https://doi.org/10.3109/21691401.2015.112961910.3109/21691401.2015.1129619 ↗
64. Sciancalepore AG et al (2014) A bioartificial renal tubule device embedding human renal stem/progenitor cells. PLoS ONE 9(1):e87496. https://doi.org/10.1371/journal.pone.008749610.1371/journal.pone.0087496 ↗
65. YS Zhang et al (2015) From cardiac tissue engineering to heart-on-a-chip: beating challenges. Biomed Mater (Bristol) 10(3) https://doi.org/10.1088/1748-6041/10/3/03400610.1088/1748-6041/10/3/034006 ↗
66. Jastrzebska E, Tomecka E, Jesion I (2016) Heart-on-a-chip based on stem cell biology. Biosens Bioelectron 75:67–81. https://doi.org/10.1016/j.bios.2015.08.01210.1016/j.bios.2015.08.012 ↗
67. Li S et al (2014) Application of an acoustofluidic perfusion bioreactor for cartilage tissue engineering. Lab Chip 14(23):4475–4485. https://doi.org/10.1039/c4lc00956h10.1039/c4lc00956h ↗
68. Mooney E, Dockery P, Greiser U, Murphy M, Barron V (2008) Carbon nanotubes and mesenchymal stem cells: biocompatibility, proliferation and differentiation. Nano Lett 8(8):2137–2143. https://doi.org/10.1021/nl073300o10.1021/nl073300o ↗
69. Konstantinov KB, Cooney CL (2014) White paper on continuous bioprocessing. May 20-21, 2014 continuous manufacturing symposium. J Pharm Sci 104(3):813–820. https://doi.org/10.1002/jps.2426810.1002/jps.24268 ↗
70. Zydney AL (2015) Perspectives on integrated continuous bioprocessing - opportunities and challenges. Curr Opin Chem Eng 10:8–13. https://doi.org/10.1016/j.coche.2015.07.00510.1016/j.coche.2015.07.005 ↗
71. Pörtner R (2015) Bioreactors for mammalian cells 89–135. https://doi.org/10.1007/978-3-319-10320-4_410.1007/978-3-319-10320-4_4 ↗
72. RD Levit et al (2013) Cellular encapsulation enhances cardiac repair. J Am Heart Assoc 2(5) https://doi.org/10.1161/JAHA.113.00036710.1161/JAHA.113.000367 ↗
73. Tabei R et al (2019) Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell-derived cardiomyocytes. J Hear Lung Transplant 38(2):203–214. https://doi.org/10.1016/j.healun.2018.11.00210.1016/j.healun.2018.11.002 ↗
74. Huang Z et al (2013) Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction. Stem Cell Res Ther 4(6):149. https://doi.org/10.1186/scrt36010.1186/scrt360 ↗
75. Gil S, Correia CR, Mano JF (2015) Magnetically labeled cells with surface-modified Fe3O4 spherical and rod-shaped magnetic nanoparticles for tissue engineering applications. Adv Healthc Mater 4(6):883–891. https://doi.org/10.1002/adhm.20140061110.1002/adhm.201400611 ↗
76. Herea DD et al (2019) Human adipose-derived stem cells loaded with drug-coated magnetic nanoparticles for in-vitro tumor cells targeting. Mater Sci Eng C 94:666–676. https://doi.org/10.1016/j.msec.2018.10.01910.1016/j.msec.2018.10.019 ↗
77. Schultze JL (2019) Myocardial infarction cell by cell. Nature Immunology 20(1):7–9. https://doi.org/10.1038/s41590-018-0277-x10.1038/s41590-018-0277-x ↗
78. Kyrtatos PG et al (2009) Magnetic tagging increases delivery of circulating progenitors in vascular injury. JACC Cardiovasc Interv 2(8):794–802. https://doi.org/10.1016/j.jcin.2009.05.01410.1016/j.jcin.2009.05.014 ↗
79. Jones CH, Chen CK, Ravikrishnan A, Rane S, Pfeifer BA (2013) Overcoming nonviral gene delivery barriers: perspective and future. Mol Pharm 10(11):4082–4098. https://doi.org/10.1021/mp400467x10.1021/mp400467x ↗
80. Kamimura K, Suda T, Zhang G, Liu D (2011) Advances in gene delivery systems. Pharm Med 25(5):293–306. https://doi.org/10.2165/11594020-000000000-0000010.2165/11594020-000000000-00000 ↗
81. Mali S (2013) Delivery systems for gene therapy. Indian J Human Genet 19(1):3–8. https://doi.org/10.4103/0971-6866.11287010.4103/0971-6866.112870 ↗
82. Pack DW, Hoffman AS, Pun S, Stayton PS (2005) Design and development of polymers for gene delivery. Nat Rev Drug Dis 4(7):581–593. https://doi.org/10.1038/nrd177510.1038/nrd1775 ↗
83. Stuckey DW, Shah K (2014) Stem cell-based therapies for cancer treatment: separating hope from hype. Nat Rev Cancer 14(10):683–691. https://doi.org/10.1038/nrc379810.1038/nrc3798 ↗
84. Smith DJ et al (2015) Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells. Proc Natl Acad Sci U S A 112(5):1523–1528. https://doi.org/10.1073/pnas.142487711210.1073/pnas.1424877112 ↗
85. Kotterman MA, Schaffer DV (2014) Engineering adeno-associated viruses for clinical gene therapy. Nat Rev Genet 15(7):445–451. https://doi.org/10.1038/nrg374210.1038/nrg3742 ↗
86. Kotterman MA, Vazin T, Schaffer DV (2015) Enhanced selective gene delivery to neural stem cells in vivo by an adeno-associated viral variant. Dev 142(10):1885–1892. https://doi.org/10.1242/dev.11525310.1242/dev.115253 ↗
87. Li S (2014) Electroporation protocols: preclinical and clinical gene medicine, 2nd edn. Humana Press, New York10.1007/978-1-4614-9632-8 ↗
88. Tavri S, Vezeridis A, Cui W, Mattrey RF (2015) In vivo transfection and detection of gene expression of stem cells preloaded with DNA-carrying microbubbles. Radiol 276(2):518–525. https://doi.org/10.1148/radiol.1514138010.1148/radiol.15141380 ↗
89. Liu Y, Wang DA (2015) Viral vector-mediated transgenic cell therapy in regenerative medicine: safety of the process. Expert Opin Biol Ther 15(4):559–567. https://doi.org/10.1517/14712598.2015.99508610.1517/14712598.2015.995086 ↗
90. Appaiahgari MB, Vrati S (2015) Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Expert Opin Biol Ther 15(3):337–351. https://doi.org/10.1517/14712598.2015.99337410.1517/14712598.2015.993374 ↗
91. Shao N, Dai T, Liu Y, Cheng Y (2015) A supramolecular approach to improve the gene transfection efficacy of dendrimers. Chem Commun 51(47):9741–9743. https://doi.org/10.1039/c5cc02300a10.1039/c5cc02300a ↗
92. Srivastava A, Cunningham C, Pandit A, Wall JG (2015) Improved gene transfection efficacy and cytocompatibility of multifunctional polyamidoamine-cross-linked hyaluronan particles. Macromol Biosci 15(5):682–690. https://doi.org/10.1002/mabi.20140040110.1002/mabi.201400401 ↗
93. Patil A et al (2018) Nanotechnology derived nanotools in biomedical perspectives: an update. Curr Nanosci 15(2):137–146. https://doi.org/10.2174/157341371466618042611285110.2174/1573413714666180426112851 ↗
94. Pickard M, Adams C, Barraud P, Chari D (2015) Using magnetic nanoparticles for gene transfer to neural stem cells: stem cell propagation method influences outcomes. J Funct Biomater 6(2):259–276. https://doi.org/10.3390/jfb602025910.3390/jfb6020259 ↗
95. Y Wang et al (2014) A magnetic nanoparticle-based multiple-gene delivery system for transfection of porcine kidney cells. PLoS One 9(7) https://doi.org/10.1371/journal.pone.010288610.1371/journal.pone.0102886 ↗
96. Dolatabadi JEN, Valizadeh H, Hamishehkar H (2015) Solid lipid nanoparticles as efficient drug and gene delivery systems: recent breakthroughs. Adv Pharm Bull 5(2):151–159. https://doi.org/10.15171/apb.2015.02210.15171/apb.2015.022 ↗
97. Wonder E et al (2016) Optimization of peptide-tagged cationic lipid nanoparticles for targeted gene delivery. Biophys J 110(3):41a. https://doi.org/10.1016/j.bpj.2015.11.28810.1016/j.bpj.2015.11.288 ↗
98. Fàbregas A et al (2014) A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid. Int J Pharm 473(1–2):270–279. https://doi.org/10.1016/j.ijpharm.2014.06.02210.1016/j.ijpharm.2014.06.022 ↗
99. Bondi ML et al (2007) Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery. J Drug Target 15(4):295–301. https://doi.org/10.1080/1061186070132469810.1080/10611860701324698 ↗
100. U Gupta (2014) Hyper-branched dendrimers in drug delivery and solubilization.SOJ Pharm Pharm Scihttps://doi.org/10.15226/2374-6866/1/3/0011310.15226/2374-6866/1/3/00113 ↗